Lyubov O. Barskaya

Lyubov O. Barskaya

Auto-generated profile, based on publicly available information

Lyubov O. Barskaya

Omsk State Medical University

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 April 2019 in Novosti Khirurgii
Verified
Journal Article
Closed access
OUOmsk State Medical University
Omsk State Medical University
VNV.N. Nikitin
V.N. Nikitin
VPV.L. Poluektov
V.L. Poluektov
TKT.P. Khramykh
T.P. Khramykh
LBL.O. Barskaya
L.O. Barskaya
VEV.P. Efanov
V.P. Efanov

2 July 2025 in I.P. Pavlov Russian Medical Biological Herald
Verified
Journal Article
Open access
PDF file
PEPavel A. Ermolaev
Pavel A. Ermolaev
TKTatyana P. Khramykh
Tatyana P. Khramykh
LBLyubov O. Barskaya
Lyubov O. Barskaya
ХПХрамых Татьяна Петровна
Храмых Татьяна Петровна
БОБарская Любовь Олеговна
Барская Любовь Олеговна
INTRODUCTION: Extracorporeal perfusion of transplants is a promising area that is actively studied to eliminate the existing shortage of donor organs. However, the optimal parameters and duration of extracorporeal perfusion that would not lead to impairment of the morphofunctional condition of transplants, have not been sufficiently studied. AIM: To present the results of development and experimental testing of an original device for perfusion preservation of an isolated heart on the biomodel. MATERIALS AND METHODS: An original perfusion device for preserving donor hearts has been developed and experimentally tested on mature outbred male rats. During 15-hour normothermic extracorporeal perfusion of the heart in the proposed device, its rhythmic and contractile function, temperature, pH of the perfusate, pressure in the aorta, hematocrit, рО2 and рСО2 in the perfusate were studied, the content of glucose, lactate, and creatine phosphokinase (CPK) activity in perfusate samples were determined. RESULTS: During perfusion of isolated hearts, sinus rhythm was observed at a sufficient rate. Perfusate pH stayed within 7.3–7.4. Hearts were perfused at constant pressure in the aorta of 70 mm Hg in normothermic conditions (t=37°С). After stabilization of the heart function, the systolic pressure in the left ventricle was 96.0 [93.7; 98.5] mm Hg and remained without significant changes during 12 hours of perfusion; at 15 hours of perfusion, the parameter decreased by 15.0% to 82.0 [79.5; 84.2] mm Hg, p=0.01208. After stabilization of the heart function, diastolic pressure in the left ventricle was 4.0 [3.0; 5.0] mm Hg and remained without significant changes during 12 hours of perfusion; by 15 hours of perfusion, it increased 1.5 times to 6.0 [5.0; 7.0] mm Hg, p=0.0164. During the experiment, biochemical markers in the perfusate after 30 min of perfusion and stabilization were at the level of physiological values without significant dynamics within 12 hours of perfusion: glucose consumption was 80.5 [70.2; 85.5] μmol/(kg×min×mm Hg); lactate excretion — 35.7 [32.5; 44.2] μmol/(kg×min×mm Hg); CPK leakage — 95.8 [93.7; 111.3] IU/l. After 15 hours of perfusion, the level of glucose consumption by isolated hearts per unit of performed function increased significantly to 136.8 [130.5; 145.7] μmol/(kg×min×mm Hg), p=0.01208; lactate excretion and CPK leakage into the perfusate increased to 58.2 [55.7; 67.4] μmol/(kg×min×mm Hg), p=0.02144, and 229.7 [215.8; 242.4] IU/L respectively, p=0.01208. CONCLUSION: The study showed that extracorporeal perfusion of the heart in the developed device allows maintaining its viability for 12 hours in conditions maximally close to physiological ones, and also conducting dynamic assessment of the functional and metabolic state of the organ.

31 July 2024 in Sechenov Medical Journal
Verified
Journal Article
Open access
PDF file
PEP. A. Ermolaev
P. A. Ermolaev
TKT. P. Khramykh
T. P. Khramykh
AVA. S. Vyaltsin
A. S. Vyaltsin
LBL. O. Barskaya
L. O. Barskaya
Aim. To test in experiment a pathogenetically adequate model of brain death due to increased intracranial pressure with gradual induction, allowing the evaluation of the changes occurring in the organs of a potential donor.Materials and methods. 6–8 months old outbred male rats of the experimental group (n = 18) and the control group (n = 8) were anesthetized, the left common carotid artery was catheterized to record systolic, diastolic blood pressure (BP) and heart rate (HR), the mean BP (MBP) was calculated. After transfer to artifi cial ventilation, brain death was simulated in the experimental group using the developed method.Results. All animals in the experimental group suffered brain death 30 minutes from the start of the experiment;10 rats (56%) died within 3 hours due to progression of circulatory failure. Initially, in anesthetized animals, MBP was 101 (90; 105) mm Hg, HR 310 (297; 315) beats/min. After 5 minutes from the start of brain death induction, MBP increased to 147 (140; 150) mm Hg (p = 0.01), HR to 396 (384; 406) beats/min (p = 0.03). Further, within 20 minutes there was a decrease in MBP to 94 (90; 100) mm Hg and HR to 290 beats/min. During the observation period from 26 to 90 minutes, there was a stabilization of MBP at the level of 87–92 mm Hg, there was a tendency to bradycardia with HR from 263 to 274 beats/min (p = 0.01). Then after 120–150 minutes from the beginning of brain death induction, MBP continued to decrease to 75–80 mmHg (p = 0,03), HR to 256–264 beats/min (p = 0,01). At the end of the experiment, despite volemic support, MBP decreased to 64 (61; 67) mm Hg (p = 0.02), bradycardia worsened with HR to 250 (248; 260) beats/min (p = 0.01), indicating the hemodynamic decompensation.Conclusion. The results of experimental testing of an animal brain death model on outbred rats showed that this model is pathogenetically adequate and useful to assess the condition of potential donor organs within 3 hours after the induction of brain death.